Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
MeiraGTx Holdings plc appointed Alan M. Sebulsky to its Board of Directors as a Class I director, effective September 23, 2026. Mr. Sebulsky, a veteran healthcare portfolio manager with over 40 years of experience, will also serve on the company's Science and Technology Committee.
Robinhood Markets CEO Vladimir Tenev Sells $32.5M of Stock
Vladimir Tenev, CEO, sold 259,166 shares of Robinhood Markets, Inc. at $125.55 to $126.15 a share (average $125.58) in 2 transactions, worth $32.5M in total on Sep 21, 2026. Shares held after the trade: 0 (-100.0%).
IIOT-OXYS, Inc. appointed Vidhyadhar Mitta to its Board of Directors, effective September 21, 2026. Mr. Mitta previously served as a director for the company and has a history of financial involvement, including a 2025 debt exchange agreement where he converted $216,156 of debt into Series E Preferred Stock.
Astrana Health, Inc. has updated its corporate investor presentation for use in upcoming conferences and meetings. The presentation includes strategic highlights and forward-looking information regarding the company's business operations and financial objectives.
Beyond Meat entered into privately negotiated exchange agreements to retire $15.0 million in principal of its 0% Convertible Senior Notes due 2027. The company is exchanging the debt at 96% of its face value for shares of common stock, with an initial issuance of 1,097,444 shares and a potential 'true up' issuance of up to 848,265 additional shares based on a three-day VWAP calculation.
Knife River Corporation filed a formal investor presentation deck (Exhibit 99.1) for its September 2026 conference activities. The presentation outlines the company's long-term investment thesis, market dynamics, and strategic 'EDGE' initiatives focused on margin improvement and vertical integration.
Adagio Medical Holdings has initiated a formal process to explore strategic alternatives, including a potential merger or sale, to maximize shareholder value. In connection with this review, the company is reducing its workforce by 58% (25 of 43 employees) and expects to incur $1.3 million in cash expenditures for severance and related costs. Additionally, the company is lowering the conversion price for its 13% Senior Secured Convertible Notes through October 31, 2026, to facilitate potential debt conversions.
McDonald's Corporation announced its new 'McDonald’s > NEXT' strategy, detailing long-term growth and productivity targets through 2030. The company aims to gain 1.5 percentage points of market share in chicken and beverages, expand operating margins to the low-to-mid 50% range, and achieve 250 basis points of restaurant-level efficiency gains.
Lakeshore Acquisition III Nasdaq/NYSE Compliance Notice
Lakeshore Acquisition III Corp. received approval from Nasdaq to transfer the listing of its units, ordinary shares, and rights from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is effective at the opening of business on September 24, 2026, and the securities will continue to trade under their existing symbols (LCCCU, LCCC, and LCCCR).
Valion Bio, Inc. appointed Dean Zikria as Interim Chief Executive Officer, effective September 22, 2026, succeeding Sheryle Bolton who stepped down from the Board. Mr. Zikria, an existing director, will receive a monthly consulting fee of $23,333 and up to 100,000 restricted stock units as part of his interim leadership agreement.
Saratoga Investment Corp. held its 2026 Annual Meeting of Stockholders on September 22, 2026. Shareholders elected G. Cabell Williams and Henri J. Steenkamp to the board of directors and ratified the selection of Ernst & Young LLP as the company's independent accounting firm for the fiscal year ending February 28, 2026.
Lantern Pharma is hosting a live webinar and investor presentation to discuss the growth plan, development roadmap, and economics of its wholly owned subsidiary, Open-Medicine AI. The session will include a live demonstration of the multi-agentic AI platform's capabilities and an overview of the subscription and enterprise licensing model.
Beneficient announced a comprehensive strategy to eliminate approximately $130 million in fraudulent debt asserted by HCLP Nominees and $850 million in preferred equity interests held by former CEO Brad Heppner following his federal fraud conviction. The company is seeking a consensual resolution to convert Heppner's massive equity stake into just 162,132 Class A shares and terminate all remaining agreements to simplify its capital structure. If a resolution is not reached before Heppner's October 2026 sentencing, the company intends to pursue litigation to void the obligations and interests.
CytoSorbents has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its stock closed at or above that level for 10 consecutive trading sessions. However, the company remains non-compliant with the $35 million Minimum Market Value of Listed Securities (MVLS) requirement and has until December 28, 2026, to resolve this deficiency.
Cracker Barrel Old Country Store Financial Results
Cracker Barrel reported Q4 fiscal 2026 total revenue of $849.3 million and GAAP net income of $12.2 million, reflecting a 2.2% revenue decrease year-over-year. During the quarter, the company reduced total debt to $337.2 million following a $150 million note repayment and a $77 million sale-leaseback transaction involving 26 store locations.
Term
Q4 2026
Earnings call
Sep 23, 2026, 8:15 AM ET
“I’m honored to lead such a differentiated and iconic brand. The Company is focused on the right areas and has a strong plan, as demonstrated by the continued improvements in the underlying traffic trend, key guest metrics, and EBITDA results. I am excited about the opportunity ahead and confident that our strategic priorities around food, experience, and people will sustain this momentum and drive long-term value creation.”
Astrana Health disclosed a material cybersecurity incident involving social engineering and unauthorized access to its systems by threat actors impersonating company personnel. The company determined the incident is material as of September 22, 2026, due to the potential compromise of sensitive patient, employee, and provider data. Remedial actions including credential resets and system restorations have been implemented while a forensic investigation remains ongoing.
Anteris Technologies Global Corp. entered into an amendment to its existing Supply & Quality Agreement with Harvey Industries Group Pty Ltd. The amendment extends the contract term until December 31, 2026, or until a new replacement agreement is executed, ensuring continued operational supply for the company's subsidiary.
SharonAI Holdings announced a collaboration with VAST Data to launch DataEnclave, a confidential AI capability integrated into Sharon AI's AI Factory platform across Australia and Asia-Pacific. The service provides a hardware-isolated secure runtime for running advanced AI models onshore, allowing regulated organizations like banks and government agencies to process sensitive data without it leaving their controlled infrastructure.
Counterparty
VAST Data
“Our customers across Australia and Asia-Pacific need to run AI at full speed without compromising on data sovereignty, and increasingly they also want access to frontier models that were previously only available offshore. Building on our sovereign data foundation with VAST DataEnclave is expected to let us host those models onshore, inside attested environments where the model owner’s weights and the customer’s data are both protected from everyone, including us.”
James Manning, Co-founder and Chief Executive Officer
Ivanhoe Electric released an updated S-K 1300 Preliminary Feasibility Study (PFS) for its Santa Cruz Copper Project in Arizona. The report replaces the previous 2025 study and provides updated technical and economic assumptions for the project's development. The company is hosting an investor call and slideshow presentation to discuss the results of the study.
Armata Pharmaceuticals received $3.7 million in additional non-dilutive funding from the U.S. Department of War to support the Phase 3 development of its AP-SA02 bacteriophage candidate. This incremental funding brings the total cumulative government support for the program to $32.4 million and is intended to fund activities for a pivotal superiority study in complicated S. aureus bacteremia.
General Mills reported fiscal 2027 first-quarter net sales of $4.4 billion, a 3% decrease primarily due to the divestiture of its U.S. yogurt business. Adjusted diluted EPS fell 13% in constant currency to $0.75, while the company reaffirmed its full-year outlook despite a volatile operating environment.
Term
Q1 2027
Earnings call
Sep 23, 2026, 9:00 AM ET
“We are off to an encouraging start in fiscal 2027, driving improved topline performance with stronger product innovation and renovation focused on the benefits consumers are looking for today.”
Jeff Harmening, General Mills Chairman and Chief Executive Officer
“We are also executing with discipline in a volatile environment, including delivering industry-leading cost savings through our Holistic Margin Management program and our global Transformation initiative. Based on our progress and the actions underway, we remain confident in our ability to deliver our fiscal 2027 guidance.”
Jeff Harmening, General Mills Chairman and Chief Executive Officer
Craig Erlich, Chief Growth Officer, bought 1,000 shares of Agree Realty Corp at $67.55 a share, worth $67.5K in total on Sep 21, 2026. Shares held after the trade: 60,388 (+1.7%).
Angi Inc. appointed Michael Steib as Chief Executive Officer, succeeding Jeffrey W. Kip who stepped down from the role and the Board effective September 22, 2026. Additionally, Joseph Levin transitioned from Executive Chairman to Chairman of the Board, and the Board size was reduced to nine members.
Keysight Technologies EVP and CFO Neil Dougherty Sells $682K of Stock
Neil Dougherty, EVP and CFO, sold 2,000 shares of Keysight Technologies, Inc. at $340.79 a share, worth $682K in total on Sep 21, 2026. Shares held after the trade: 123,390 (-1.6%).
KE Holdings Executive Director Yigang Shan Sells $18.1M of Stock
Yigang Shan, Executive Director, sold 3,326,670 shares of KE Holdings Inc. at $5.44 a share, worth $18.1M in total on Sep 21, 2026. Shares held after the trade: 53,868,189 (-5.8%).
Ionis and partner Roche announced positive interim results from the Phase 3 IMAgINATION study of sefaxersen in adults with IgA nephropathy (IgAN). The study met its primary endpoint, demonstrating statistically significant and clinically meaningful reductions in proteinuria compared to placebo at 37 weeks.
Counterparty
Roche Holding Ltd.
“With these positive interim results, sefaxersen is positioned to directly address a primary driver of IgAN-related kidney damage, offering the potential to help slow disease progression and potentially reduce the long-term need for dialysis or kidney transplantation.”
Brett P. Monia, Ph.D., chief executive officer, Ionis
Royal Caribbean Cruises Signs $3B M&A Deal with Sandals and Beaches Resorts
Royal Caribbean Cruises Ltd. has entered into a definitive agreement to acquire a 50% equity interest in Sandals and Beaches Resorts for approximately $3.0 billion in cash. The transaction, funded by committed debt financing from Morgan Stanley, expands Royal Caribbean's vacation platform into the all-inclusive resort space and is expected to close in early 2027.
Artificial Intelligence Technology Solutions Business Update
Artificial Intelligence Technology Solutions' subsidiary, RAD, received its third order from national dealer Third Order within seven weeks. The order includes two RIO Mini systems and one AVA unit to support security operations for a major construction equipment company in North Carolina. This update highlights the expanding product mix and market reach of RAD's AI-driven security portfolio across different end-user settings.
Arthur C. Butcher, Executive Vice President and Group President of MedSurg and Asia Pacific, has announced his retirement effective January 1, 2027. He will serve as a senior advisor through February 26, 2027, maintaining his current annual base salary of $780,000 during the transition period.
Yanjun Wang, CCO and GC, sold 2,400 shares of Sea Ltd at $100.69 to $103.80 a share (average $102.75) in 5 transactions, worth $247K in total between Sep 21, 2026 and Sep 22, 2026. Shares held after the trade: 96,380 (-0.9%).